Royalty Pharma plc
NASDAQ:RPRX · NASDAQ Global Select
-$0.87 today
Vol 8.57M · Avg 3.61M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+52.84%
Period High
$55.87
Period Low
$34.37
Latest
$52.96
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
United Therapeutics Corporation
NASDAQ:UTHR
$22.64B
Roivant Sciences Ltd.
NASDAQ:ROIV
$22.59B
Incyte Corporation
NASDAQ:INCY
$19.63B
Hologic, Inc.
HOLX
$16.97B
Genmab A/S
NASDAQ:GMAB
$15.54B
Tenet Healthcare Corporation
NYSE:THC
$14.86B
Exelixis, Inc.
NASDAQ:EXEL
$13.08B
Smith & Nephew plc
NYSE:SNN
$12.76B
Fresenius Medical Care AG & Co. KGaA
NYSE:FMS
$12.67B
Summit Therapeutics Inc.
NASDAQ:SMMT
$10.65B
What is the latest RPRX filing?
The latest filing shown is SC 13D/A dated Jun 16, 2026.
How many recent filings does RPRX have?
Intrinsic Alpha currently shows 20 recent filings for RPRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.